With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Prognostic and Therapeutic Significance of Stem Cell Heterogeneity in AML||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD||'A' Award Grants||2012||Washington|
|Genomic Alterations in ETV6 Predict Outcome in Pediatric AML||Fred Hutchinson Cancer Research Center / Heather Helton, MD||Young Investigator Grants||2013||Washington|
|Novel Antibodies to the C2-set Domain of CD33 for Acute Myeloid Leukemia Immunotherapy||Fred Hutchinson Cancer Research Center / Colin Godwin, MD||Young Investigator Grants||2018||Washington|
|Characterization of Chromatin Landscapes to Identify Therapeutic Vulnerabilities in Diffuse Midline Gliomas.||Fred Hutchinson Cancer Research Center / Jay Sarthy, MD/PhD||Young Investigator Grants||2019||Washington|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|
|Restoring RUNX1 Levels in FPD/AML||University of Washington, Seattle / Marshall Horwitz, MD/PhD||Familial RUNX1 Research Grants||2016||Washington|
|Aberrant DNA methylation in Ewing sarcoma.||Fred Hutchinson Cancer Research Center / Scott Borinstein||Young Investigator Grants||2009||Washington|
|Establishing the Function of Novel MicroRNAs Associated with Resistance and Relapse in Pediatric AML||Fred Hutchinson Cancer Research Center / Vivian Oehler, MD & Soheil Meshinchi, MD/PhD||Innovation Grants||2017||Washington|
|Molecular Signature of Inflammation||Medical College of Wisconsin / Subramaniam Malarkannan, PhD||Springboard Grants||2013||Wisconsin|
|Phase I Study of Lentivirus Engineered Autologous AML Cells Expressing IL-12 in Children and Young Adults with Relapsed AML||Children's Hospital of Wisconsin - Milwaukee / Michael Burke, MD & Jeffrey Medin, MD/PhD||Reach Grants||2017||Wisconsin|